These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35904048)

  • 21. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
    Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diastolic Blood Pressure, Subclinical Myocardial Damage, and Cardiac Events: Implications for Blood Pressure Control.
    McEvoy JW; Chen Y; Rawlings A; Hoogeveen RC; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    J Am Coll Cardiol; 2016 Oct; 68(16):1713-1722. PubMed ID: 27590090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of minimal elevation in high-sensitivity cardiac troponin T in the general population.
    Rubin J; Matsushita K; Lazo M; Ballantyne CM; Nambi V; Hoogeveen R; Sharrett AR; Blumenthal RS; Coresh J; Selvin E
    Clin Biochem; 2016 Jun; 49(9):657-662. PubMed ID: 26975902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical cardiovascular disease and frailty risk: the atherosclerosis risk in communities study.
    Jia Y; Li D; Yu J; Liu Y; Li F; Li W; Zhang Q; Gao Y; Zhang W; Zeng Z; Zeng R; Liao X; Zhao Q; Wan Z
    BMC Geriatr; 2022 Apr; 22(1):321. PubMed ID: 35413794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer Survivorship and Subclinical Myocardial Damage.
    Florido R; Lee AK; McEvoy JW; Hoogeveen RC; Koton S; Vitolins MZ; Shenoy C; Russell SD; Blumenthal RS; Ndumele CE; Ballantyne CM; Joshu CE; Platz EA; Selvin E
    Am J Epidemiol; 2019 Dec; 188(12):2188-2195. PubMed ID: 30927355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic hyperglycemia and subclinical myocardial injury.
    Rubin J; Matsushita K; Ballantyne CM; Hoogeveen R; Coresh J; Selvin E
    J Am Coll Cardiol; 2012 Jan; 59(5):484-9. PubMed ID: 22281251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study.
    Ebong IA; Wilson MD; Bertoni AG; Appiah D; Polonsky T; Michos ED; Ballantyne C; Chang P
    Menopause; 2021 Jan; 28(3):284-291. PubMed ID: 33399316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of subclinical myocardial necrosis using high-sensitivity cardiac troponin T in patients with prediabetes.
    Witkowski M; Wu Y; Hazen SL; Tang WHW
    Cardiovasc Diabetol; 2021 Aug; 20(1):171. PubMed ID: 34419046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-sensitivity cardiac troponin T and cognitive function and dementia risk: the atherosclerosis risk in communities study.
    Schneider AL; Rawlings AM; Sharrett AR; Alonso A; Mosley TH; Hoogeveen RC; Ballantyne CM; Gottesman RF; Selvin E
    Eur Heart J; 2014 Jul; 35(27):1817-24. PubMed ID: 24685712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subclinical Cardiovascular Disease in US Adults With and Without Diabetes.
    Fang M; Wang D; Tang O; McEvoy JW; Echouffo-Tcheugui JB; Christenson RH; Selvin E
    J Am Heart Assoc; 2023 Jun; 12(11):e029083. PubMed ID: 37254959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ishigami J; Kim Y; Sang Y; Menez SP; Grams ME; Skali H; Shah AM; Hoogeveen RC; Selvin E; Solomon SD; Ballantyne CM; Coresh J; Matsushita K
    Clin Chem; 2021 Jan; 67(1):298-307. PubMed ID: 33418586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of liver enzymes with biomarkers of subclinical myocardial damage and structural heart disease.
    Lazo M; Rubin J; Clark JM; Coresh J; Schneider AL; Ndumele C; Hoogeveen RC; Ballantyne CM; Selvin E
    J Hepatol; 2015 Apr; 62(4):841-7. PubMed ID: 25433159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal Changes of Stable High-Sensitivity Cardiac Troponin T Levels and Prognosis.
    Roos A; Edgren G; Holzmann MJ
    J Am Heart Assoc; 2022 Jun; 11(11):e025082. PubMed ID: 35621209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
    Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
    Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
    [No Abstract]   [Full Text] [Related]  

  • 36. High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.
    Filion KB; Agarwal SK; Ballantyne CM; Eberg M; Hoogeveen RC; Huxley RR; Loehr LR; Nambi V; Soliman EZ; Alonso A
    Am Heart J; 2015 Jan; 169(1):31-8.e3. PubMed ID: 25497245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise training and high-sensitivity cardiac troponin T in patients with heart failure with reduced ejection fraction.
    Koppen E; Omland T; Larsen AI; Karlsen T; Linke A; Prescott E; Halle M; Dalen H; Delagardelle C; Hole T; van Craenenbroeck EM; Beckers P; Ellingsen Ø; Feiereisen P; Valborgland T; Videm V;
    ESC Heart Fail; 2021 Jun; 8(3):2183-2192. PubMed ID: 33754453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of Cardiac, Kidney, and Diabetes Biomarkers With Peripheral Neuropathy among Older Adults in the Atherosclerosis Risk in Communities (ARIC) Study.
    Hicks CW; Wang D; Daya NR; Windham BG; Ballantyne CM; Matsushita K; Selvin E
    Clin Chem; 2020 May; 66(5):686-696. PubMed ID: 32268368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alcohol Consumption and Cardiac Biomarkers: The Atherosclerosis Risk in Communities (ARIC) Study.
    Lazo M; Chen Y; McEvoy JW; Ndumele C; Konety S; Ballantyne CM; Sharrett AR; Selvin E
    Clin Chem; 2016 Sep; 62(9):1202-10. PubMed ID: 27440513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth Differentiation Factor (GDF)-15 and Cardiometabolic Outcomes among Older Adults: The Atherosclerosis Risk in Communities Study.
    Echouffo-Tcheugui JB; Daya N; Matsushita K; Wang D; Ndumele CE; Al Rifai M; Hoogeveen RC; Ballantyne CM; Selvin E
    Clin Chem; 2021 Mar; 67(4):653-661. PubMed ID: 33582779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.